LVCLY

Living Cell Technologies Ltd.

 
Sponsored ADR (1 ADS : 10 Ordinary) International Reporting
OTCQX International OTCQX Advisor: BNY Mellon
Verified Company Profile 7/19/2016
Contact Info
  • Level 7
  • 330 Collins Street
  • GPO Box 4231
  • Melbourne, VIC 3000
  • Australia

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Jun 30, 2016 Quarterly Report
CIK 0001398773
Fiscal Year End 6/30
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Business Status Development Stage Company a/o
Incorporated In: New South Wales, Australia
Year of Inc. 2003
Employees 60 a/o Dec 19, 2012
Company Officers/Contacts
Ken R. Taylor CEO
John Cowan Head of Finance
Mark Licciardo Company Secretary
Company Directors
Roy Austin Chairman
Laurie Hunter
Bernard Tuch
Robert Willcocks
Service Providers
OTCQX Advisor
BNY Mellon
101 Barclay Street
22nd Floor
New York, NY, 10286
USA

Accounting/Auditing Firm
BDO East Coast Partnership
Level 11, 1 Margaret Street
Sydney, NSW, 2000
Australia

Legal Counsel
Not Available
Investor Relations Firm
Not Available
LVCLY Security Details Other Company Securities
Share Structure
Market Value1 $34,257,695 a/o Dec 09, 2016
Authorized Shares Unlimited a/o Feb 02, 2015
Outstanding Shares 496,488,328 a/o Jun 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 227,100,000 a/o Jun 30, 2012
Par Value No Par Value
Transfer Agent(s)
BNY Mellon
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
LCT - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 82 (0%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security